Stay Connected: LinkedIn
Mederi Logo

Mederi’s innovative products offer proven solutions to the debilitating digestive disorders called gastroesophageal reflux disease (GERD) and bowel control disorder (BCD). GERD and BCD collectively affect tens of millions of sufferers worldwide. Mederi Therapeutics’ products, Stretta for GERD and Secca for BCD, are minimally invasive treatments that bridge the gap between conservative measures and invasive surgery or implants. Secca and Stretta use radiofrequency (RF) energy to remodel the muscles that control the entry and exit of the human digestive system...allowing patients to experience significantly fewer symptoms and lead much more fulfilling lives.

SeccaStrettaSecca Patients & Familiessecca hcpstretta pafstretta hcp
Please email for access to the training modules.
February 24, 2014 - Stretta for GERD Remains Highly Effective 10 Years After Treatment.
Newly Published Study in the February Online Edition of Surgical Endoscopy.

December 23, 2013 - Mederi Expands on Growing Use of Stretta and Secca Therapies.
Mederi Therapeutics Closes Funding of $18.5 Million - click here for the Press Release.

November 26, 2013 - Stretta Therapy Featured on CBS New Orleans with Dr. Gary Reiss.
New Procedure Helps Get Rid of Chronic Reflux.

November 13, 2013 - Q&A with Dr. Steve Schwaitzberg in Surgical Products News.
Q&A: Evaluating The Effectiveness of Stretta as a Treatment for GERD.

October, 2013 - Stretta Therapy Featured on Fox News Health
New Technology Cures GERD without Surgery.

September 5, 2013 - New study concludes Stretta may be more desirable than chronic PPIs or anti-reflux surgery!
Stretta RF Treatment for GERD - a safe and effective modality - click here for the Press Release.

May 19, 2013 - Stretta 10-Year Data Presented at DDW2013
Stretta procedure for GERD shows sustained symptom improvement and long term efficacy - click here for the Press Release.

April 2, 2013 - Stretta and SAGES Guidelines Featured in Gastroenterology and Endoscopy News
Click here for the article in the April Issue - SAGES Issues Recommendations on Endoluminal Therapies to Treat GERD

March 4, 2013 - Stretta, an Innovative treatment for Gastric Reflux featured on MBC Green Apples TV in Lebanon
MBC's health program features Stretta therapy at Clemenceau Hospital in Beirut - click here for the Press Release.

February 7, 2013 - Stretta for GERD receives strongest recommendation in SAGES new Clinical Guideline!
Click here for a link to the SAGES Clinical Spotlight Review - Endoluminal Treatment for GERD

October 18, 2012 - Mederi now in 35 countries!
Mederi Therapeutics Signs with Farouq, Maamoun, Tamer & Co. to Distribute the New Stretta and Secca Systems in the KSA

New Meta-Analysis Shows Stretta Significantly Improves Reflux Symptoms and Reduces Acid Exposure